Brannan Stephen K.'s Form 4 filing
Karuna Therapeutics, Inc. (KRTX) · filed Jan 9, 2023
- Accession no.
- 0001593968-23-000108
- Filed
- Jan 9, 2023
- Trade date
- Jan 9, 2023
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $987.6K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Brannan Stephen K.CIK 0001777631 | Officer (Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 9, 2023 | Common Stock | MOption exerciseAcquired | +1,527 | $5.45 | +$8,322.15 | 16,527 | Direct | |
| Jan 9, 2023 | Common Stock | SSaleDisposed | −1,527 | $197.52 | −$301,613.04 | 15,000 | Direct | |
| Jan 9, 2023 | Common Stock | MOption exerciseAcquired | +3,473 | $7.27 | +$25,248.71 | 18,473 | Direct | |
| Jan 9, 2023 | Common Stock | SSaleDisposed | −3,473 | $197.52 | −$685,986.96 | 15,000 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 9, 2023 | Common Stock | MOption exerciseDisposed | −1,527 | $0.00 | $0 | 34,677 | Direct | |
| Jan 9, 2023 | Common Stock | MOption exerciseDisposed | −3,473 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.